YONGHE MED.GR.DL-0000025 (L97) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.14x

YONGHE MED.GR.DL-0000025 (L97) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting €68.90 Million (capex €18.90 Million plus investments €-50.00 Million) from operating cash flow of €495.53 Million. Explore YONGHE MED.GR.DL-0000025 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

€68.90 Million
Capex + Investments

Operating Cash Flow

€495.53 Million
EUR

Capital Expenditures

€18.90 Million
EUR

YONGHE MED.GR.DL-0000025 Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for YONGHE MED.GR.DL-0000025 across 3 annual periods. Also explore L97 total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for YONGHE MED.GR.DL-0000025 (2021–2025)

Year-by-year capital reinvestment analysis for YONGHE MED.GR.DL-0000025. For live market cap and broader valuation context, see how much is YONGHE MED.GR.DL-0000025 worth.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.14x €68.90 Million €495.53 Million €18.90 Million ▼ -40.9%
2024 0.24x €53.76 Million €228.62 Million €53.76 Million ▼ -46.1%
2021 0.44x €190.64 Million €437.28 Million €190.64 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow